The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
SHP2 promotes RAS-driven MAPK signalling, but it is unclear why cancer cells with distinct KRAS mutations exhibit differential sensitivity to SHP2 inhibition. Here the authors show that KRAS Q61H is decoupled from SHP2- mediated upstream regulation, thus Q61H pancreatic cancer cells maintain MAPK si...
Guardado en:
Autores principales: | Teklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, Nikolina Radulovich, Molly L. Udaskin, Ahmet Mentes, Richard Huang, Betty P. K. Poon, Wenguang He, Ivette Valencia-Sama, Claire M. Robinson, Melissa Huestis, Jinmin Miao, Jen Jen Yeh, Zhong-Yin Zhang, Meredith S. Irwin, Jeffrey E. Lee, Ming-Sound Tsao, Brian Raught, Christopher B. Marshall, Michael Ohh, Mitsuhiko Ikura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/adc5eaa39af340409424aef1fcf1144b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
por: Yoshihito Kano, et al.
Publicado: (2019) -
Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
por: Xiaozheng Xu, et al.
Publicado: (2021) -
Acta No. 61
por: Banco Central de Chile
Publicado: (2019) -
Editorial 61-4
por: Maria Cristina Fréres de Souza
Publicado: (2015) -
Editorial 61-2
por: Maria Cristina Fréres de Souza
Publicado: (2015)